PT  - JOURNAL ARTICLE
AU  - Zad, Zahra
AU  - Jiang, Victoria S.
AU  - Wolf, Amber T.
AU  - Wang, Taiyao
AU  - Cheng, J. Jojo
AU  - Paschalidis, Ioannis Ch.
AU  - Mahalingaiah, Shruthi
TI  - Predicting polycystic ovary syndrome (PCOS) with machine learning algorithms from electronic health records
AID  - 10.1101/2023.07.27.23293255
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.07.27.23293255
4099  - http://medrxiv.org/content/early/2023/10/01/2023.07.27.23293255.short
4100  - http://medrxiv.org/content/early/2023/10/01/2023.07.27.23293255.full
AB  - Introduction Predictive models have been used to aid early diagnosis of PCOS, though existing models are based on small sample sizes and limited to fertility clinic populations. We built a predictive model using machine learning algorithms based on an outpatient population at risk for PCOS to predict risk and facilitate earlier diagnosis, particularly among those who meet diagnostic criteria but have not received a diagnosis.Methods This is a retrospective cohort study from a SafetyNet hospital’s electronic health records (EHR) from 2003-2016. The study population included 30,601 women aged 18-45 years without concurrent endocrinopathy who had any visit to Boston Medical Center for primary care, obstetrics and gynecology, endocrinology, family medicine, or general internal medicine. Four prediction outcomes were assessed for PCOS. The first outcome was PCOS ICD-9 diagnosis with additional model outcomes of algorithm-defined PCOS. The latter was based on Rotterdam criteria and merging laboratory values, radiographic imaging, and ICD data from the EHR to define irregular menstruation, hyperandrogenism, and polycystic ovarian morphology on ultrasound.Results We developed predictive models using four machine learning methods: logistic regression, supported vector machine, gradient boosted trees, and random forests. Hormone values (follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone binding globulin) were combined to create a multilayer perceptron score using a neural network classifier. Prediction of PCOS prior to clinical diagnosis in an out-of-sample test set of patients achieved AUC of 85%, 81%, 80%, and 82%, respectively in Models I, II, III and IV. Significant positive predictors of PCOS diagnosis across models included hormone levels and obesity; negative predictors included gravidity and positive bHCG.Conclusions Machine learning algorithms were used to predict PCOS based on a large at-risk population. This approach may guide early detection of PCOS within EHR-interfaced populations to facilitate counseling and interventions that may reduce long-term health consequences. Our model illustrates the potential benefits of an artificial intelligence-enabled provider assistance tool that can be integrated into the EHR to reduce delays in diagnosis. However, model validation in other hospital-based populations is necessary.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Institutes of Health (R01 GM135930), National Institutes of Health (UL54 TR004130), Boston University Kilachand Fund for Integrated Life Science and Engineering, National Science Foundation (CCF-2200052), National Science Foundation (IIS-1914792), and National Science Foundation (DMS-1664644).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Boston University School of Medicine and the Harvard T.H. Chan School of Public Health (Protocol # H35708) agave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.